Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
34.09
+0.65 (1.94%)
At close: May 8, 2025, 4:00 PM
34.40
+0.31 (0.91%)
Pre-market: May 9, 2025, 4:16 AM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $1.96 billion as of May 9, 2025. Its market cap has increased by 17.44% in one year.
Market Cap
1.96B
Enterprise Value
1.63B
1-Year Change
17.44%
Ranking
Category
Stock Price
$34.09
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.96B, an increase of 324.61%. That is a compound annual growth rate of 35.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 1.92B | -2.15% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | 2.06B | 346.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.85B |
| Johnson & Johnson | 371.67B |
| UnitedHealth Group | 359.09B |
| AbbVie | 331.06B |
| Novo Nordisk | 297.73B |
| Abbott Laboratories | 231.50B |
| AstraZeneca | 221.83B |
| Novartis AG | 220.92B |